Creating and sharing synthetic data for HIV research
Creating, evaluating, and sharing synthetic data for multinational HIV cohorts
['FUNDING_R01'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-11084839
This study is working on using smart computer techniques to create fake health data that looks like real information about HIV patients, helping researchers share important health insights while keeping your privacy safe, which could eventually lead to better treatments for HIV.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (NASHVILLE, UNITED STATES) |
| Trial ID | NIH-11084839 on ClinicalTrials.gov |
What this research studies
This research focuses on developing advanced artificial intelligence methods to create synthetic data that mimics real HIV cohort data while ensuring patient privacy. By generating this synthetic data, researchers aim to overcome the limitations imposed by data privacy laws, allowing for broader access to valuable health information. The project will evaluate the effectiveness of these synthetic datasets in supporting scientific discoveries and improving the reproducibility of findings in HIV research. Patients may benefit indirectly as this research could lead to better-informed studies and treatments for HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals involved in HIV cohorts or those interested in the advancements of HIV treatment and research methodologies.
Not a fit: Patients who are not part of HIV cohorts or those not interested in research advancements related to HIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance the understanding and treatment of HIV by enabling more researchers to access and analyze data without compromising patient privacy.
How similar studies have performed: While synthetic data generation is a growing field, this specific approach tailored for HIV cohort data is relatively novel and has not been extensively tested in previous studies.
Where this research is happening
NASHVILLE, UNITED STATES
- VANDERBILT UNIVERSITY MEDICAL CENTER — NASHVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SHEPHERD, BRYAN EARL — VANDERBILT UNIVERSITY MEDICAL CENTER
- Study coordinator: SHEPHERD, BRYAN EARL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus